Complete clinical response of metastatic hepatocellular carcinoma to sorafenib in a patient with hemochromatosis: A case report

被引：40

作者：

So, Brian J. ^{[1
]}

Bekaii-Saab, Tanios ^{[1
]}

Bloomston, Mark A. ^{[1
]}

Patel, Tushar ^{[1
]}

机构：

[1] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA

来源：

JOURNAL OF HEMATOLOGY & ONCOLOGY | 2008年 / 1卷 / 1期

关键词：

Renal Cell Carcinoma; Complete Remission; Sorafenib; Gastrointestinal Stromal Tumor; Hemochromatosis;

D O I：

10.1186/1756-8722-1-18

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Hepatocellular carcinoma is rare, but increasing in prevalence in the United States. Recent studies have shown that sorafenib, a multikinase inhibitor, can reduce tumor progression in patients with this cancer. However, complete remission has not been observed. We report a case of a 78-year old patient with unresectable metastatic hepatocellular carcinoma who had a rapid and complete clinical response following therapy with sorafenib for six months. No evidence of disease recurrence has been noted for 6 months after discontinuation of therapy.

引用

页数：3

共 5 条

[1] Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models [J].

Chang, Yong S. ;

Adnane, Jalila ;

Trail, Pamela A. ;

Levy, Joan ;

Henderson, Arris ;

Xue, Dahai ;

Bortolon, Elizabeth ;

Ichetovkin, Marina ;

Chen, Charles ;

McNabola, Angela ;

Wilkie, Dean ;

Carter, Christopher A. ;

Taylor, Ian C. A. ;

Lynch, Mark ;

Wilhelm, Scott .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (05) :561-574

[2] Sorafenib in advanced hepatocellular carcinoma [J].

Llovet, Josep M. ;

Ricci, Sergio ;

Mazzaferro, Vincenzo ;

Hilgard, Philip ;

Gane, Edward ;

Blanc, Jean-Frederic ;

Cosme de Oliveira, Andre ;

Santoro, Armando ;

Raoul, Jean-Luc ;

Forner, Alejandro ;

Schwartz, Myron ;

Porta, Camillo ;

Zeuzem, Stefan ;

Bolondi, Luigi ;

Greten, Tim F. ;

Galle, Peter R. ;

Seitz, Jean-Francois ;

Borbath, Ivan ;

Haussinger, Dieter ;

Giannaris, Tom ;

Shan, Minghua ;

Moscovici, Marius ;

Voliotis, Dimitris ;

Bruix, Jordi .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (04) :378-390

[3] Systematic review: evidence-based management of hepatocellular carcinoma - an updated analysis of randomized controlled trials [J].

Lopez, P. M. ;

Villanueva, A. ;

Llovet, J. M. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (11) :1535-1547

[4] Global cancer statistics, 2002 [J].

Parkin, DM ;

Bray, F ;

Ferlay, J ;

Pisani, P .

CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (02) :74-108

[5] BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis [J].

Wilhelm, SM ;

Carter, C ;

Tang, LY ;

Wilkie, D ;

McNabola, A ;

Rong, H ;

Chen, C ;

Zhang, XM ;

Vincent, P ;

McHugh, M ;

Cao, YC ;

Shujath, J ;

Gawlak, S ;

Eveleigh, D ;

Rowley, B ;

Liu, L ;

Adnane, L ;

Lynch, M ;

Auclair, D ;

Taylor, I ;

Gedrich, R ;

Voznesensky, A ;

Riedl, B ;

Post, LE ;

Bollag, G ;

Trail, PA .

CANCER RESEARCH, 2004, 64 (19) :7099-7109

← 1 →